Jove
Visualize
Contact Us

Related Experiment Videos

Erythrodermic (exfoliative) psoriasis

E M Farber1, L Nall

  • 1Psoriasis Research Institute, Palo Alto, California 94301.

Cutis
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Erythrodermic psoriasis is a severe, challenging skin condition. Identifying triggers and using systemic and topical treatments are key to managing this psoriasis type effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical testing of new drugs for lesional skin diseases such as psoriasis A new delivery system.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016
Same author

Evaluation of beta-dimethylaminoethyl benzhydryl ether hydrochloride (benadryl) in the treatment of urticaria, scleroderma and allied disturbances.

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Ulcer of the leg due to arteriolosclerosis and ischemia, occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers).

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Benadryl in the treatment of urticaria.

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Ulcer of the leg due to arteriosclerosis and ischemia occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers) a preliminary report.

Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.)·2010
Same author

Benadryl in the treatment of certain diseases of the skin.

Journal of the American Medical Association·2010
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Dermatology
  • Clinical Medicine

Background:

  • Erythrodermic psoriasis is a severe variant of psoriasis.
  • It presents significant treatment challenges requiring expert clinical management.

Purpose of the Study:

  • To highlight the complexities of treating erythrodermic psoriasis.
  • To emphasize the importance of identifying and managing precipitating factors.
  • To underscore the necessity of combined therapeutic approaches.

Main Methods:

  • Clinical observation and analysis of patient cases.
  • Review of precipitating factors in erythrodermic psoriasis.
  • Evaluation of systemic and topical treatment strategies.

Main Results:

  • Erythrodermic psoriasis demands sophisticated clinical expertise.

Related Experiment Videos

  • Understanding and addressing triggers can prevent disease relapse.
  • Integrated treatment plans are crucial for successful outcomes.

    • Conclusions:

    • Effective management of erythrodermic psoriasis relies on skilled clinical judgment.
    • Preventing recurrences involves diligent identification of precipitating factors.
    • A combination of systemic and topical therapies is essential for favorable patient outcomes.